Literature DB >> 17960073

Heterocycles [h]fused onto 4-oxoquinoline-3-carboxylic acid, part IV. Convenient synthesis of substituted hexahydro [1,4]thiazepino[2,3-h]quinoline-9-carboxylic acid and its tetrahydroquino[7,8-b]benzothiazepine homolog.

Mohammed H Al-Huniti1, Mustafa M El-Abadelah, Jalal A Zahra, Salim S Sabri, Arnd Ingendoh.   

Abstract

Substituted [1,4]thiazepino[2,3-h]quinolinecarboxylic acid 3 is prepared by PPA-catalyzed thermal lactamization of the respective 8-amino-7-[(2-carboxyethyl)thio]-1,4-dihydroquinoline-3-carboxylic acid 9. The latter synthon is obtained by reduction of the 8-nitro-1,4-dihydroquinoline precursor 8 which, in turn, is made accessible via interaction of 3-mercaptopropionic acid with 7-chloro-1-cyclopropyl-6-fluoro-8-nitro-1,4-dihydroquinoline-3-carboxylic acid 7 in the presence of triethylamine. A benzo-homolog of 3, namely tetrahydroquino[7,8-b]benzothiazepine-3-carboxylic acid 6, is analogously prepared via the reaction of 2-mercaptobenzoic acid with 7, followed by reduction of the resulting 7-[(2-carboxyphenyl)thio]-8-nitro product 10 into the corresponding 8-amino derivative 11, and subsequent lactamization. The structures assigned to 3, 6 and 8-11 are based on microanalytical and spectral (IR, MS, NMR) data.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960073      PMCID: PMC6149087          DOI: 10.3390/12081558

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  26 in total

1.  Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.

Authors:  J P Sanchez; J M Domagala; S E Hagen; C L Heifetz; M P Hutt; J B Nichols; A K Trehan
Journal:  J Med Chem       Date:  1988-05       Impact factor: 7.446

Review 2.  Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.

Authors:  Lester A Mitscher
Journal:  Chem Rev       Date:  2005-02       Impact factor: 60.622

3.  Molecular geometries of dibenzothiazepinone and dibenzoxazepinone calcium antagonists.

Authors:  R Li; P S Farmer; J Wang; R J Boyd; T S Cameron; M A Quilliam; J A Walter; S E Howlett
Journal:  Drug Des Discov       Date:  1995-04

4.  Enhanced antitumor activity of ultrasonic irradiation in the presence of new quinolone antibiotics in vitro.

Authors:  Deqing Huang; Kyoji Okada; Chiyo Komori; Eiji Itoi; Toshio Suzuki
Journal:  Cancer Sci       Date:  2004-10       Impact factor: 6.716

5.  Characterization of the vasoinhibitory actions of KT2-230, a new benzothiazepine vasodilator derivative on isolated rabbit vascular smooth muscles: an alpha-adrenergic- and serotonergic-receptor antagonist.

Authors:  S Shibata; N Satake; R K Hester; S Mochizuki; K Kosakai; N Ueyama; S Wakabayashi
Journal:  Gen Pharmacol       Date:  1991

Review 6.  The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors.

Authors:  Q Li; L A Mitscher; L L Shen
Journal:  Med Res Rev       Date:  2000-07       Impact factor: 12.944

7.  SUBSTITUTED 2,3-DIHYDRO-1,5-BENZOTHIAZEPIN-4(5H)-ONES AND 3,4-DIHYDRO-2-PHENYL-(2H)-1,6-BENZOTHIAZOCIN-5(6H)-ONES.

Authors:  J KRAPCHO; E R SPITZMILLER; C F TURK
Journal:  J Med Chem       Date:  1963-09       Impact factor: 7.446

8.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

9.  Dibenzothiazepinones as potential calcium channel antagonists. I.

Authors:  R Li; P S Farmer; M A Quillam; S E Howlett
Journal:  Drug Des Discov       Date:  1993

10.  Quinolone action against human topoisomerase IIalpha: stimulation of enzyme-mediated double-stranded DNA cleavage.

Authors:  Kenneth D Bromberg; Alex B Burgin; Neil Osheroff
Journal:  Biochemistry       Date:  2003-04-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.